US2017319601A1PendingUtilityA1
Treatment of submental fat
Assignee: KYTHERA BIOPHARMACEUTICALS INCPriority: Feb 18, 2011Filed: Jul 18, 2017Published: Nov 9, 2017
Est. expiryFeb 18, 2031(~4.6 yrs left)· nominal 20-yr term from priority
Inventors:Patricia Walker
A61P 41/00A61P 43/00A61P 7/02A61P 31/00A61P 29/00A61K 9/0019A61K 38/465A61K 31/575A61P 1/12A61K 47/10A61K 31/56A61K 31/167A61K 47/24A61K 45/06
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure relates to compositions, kits and methods for non-surgical reduction of localized subcutaneous fat such as that associated with a cosmetic fat accumulation. The methods employ compositions having specific concentrations of a salt of deoxycholic acid which provides a superior fat cell necrosis with modest adverse effects. Examples of localized subcutaneous fat are found in the submental area, in particular under the chin.
Claims
exact text as granted — not AI-modified1 - 20 . (canceled)
21 . A method for decreasing submental fat in a subject, said method comprising
(a) applying a grid pattern to mark injection sites spaced about 1.0 cm apart from each other at a treatment area of the subject; and (b) administering a plurality of subcutaneous injections to the treatment area, one injection administered per injection site as marked by the grid pattern;
wherein each injection comprises a solution comprising 2 mg of deoxycholic acid, or a salt thereof; each injection has a volume of 0.2 mL; and each injection is administered at a depth of approximately mid-way into the submental fat.
22 . The method of claim 21 , further comprising palpating the treatment area prior to administering the plurality of subcutaneous injections.
23 . The method of claim 21 , further comprising massaging the treatment area after completion of the administration of the plurality of subcutaneous injections.
24 . The method of claim 21 , wherein the plurality of subcutaneous injections has a total volume of up to 10 mL.
25 . The method of claim 21 , wherein the plurality of subcutaneous injections contains up to 50 injections.
26 . The method of claim 21 , wherein steps (a) and (b) are repeated up to 6 times.
27 . The method of claim 26 , wherein steps (a) and (b) are repeated at 4-week (±5 days) intervals.
28 . The method of claim 21 , wherein the grid pattern comprises a plurality of spots, each spot spaced about 1.0 cm apart from each other.
29 . The method of claim 28 , wherein one injection is administered at each spot.
30 . The method of claim 28 , wherein the plurality of spots comprises at least 20 spots.
31 . The method of claim 21 , wherein each injection is administered using a syringe with a 30-gauge, 0.5-inch needle.Join the waitlist — get patent alerts
Track US2017319601A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.